Valuation: LifeMD, Inc.

Market Cap 236M 206M 189M 176M 335M 22.43B 340M 2.27B 883M 11.02B 884M 865M 37.99B P/E 2026 *
-17.8x
P/E 2027 * 65.6x
Enterprise Value 236M 206M 189M 176M 335M 22.43B 340M 2.27B 883M 11.02B 884M 865M 37.99B EV / Sales 2026 *
1.06x
EV / Sales 2027 * 0.9x
Free-Float
85.9%
Yield 2026 *
-
Yield 2027 * -
1 day+7.27%
1 week+17.92%
Current month+17.92%
1 month+6.80%
3 months+38.75%
6 months+39.54%
Current year+42.82%
1 week 3.9
Extreme 3.9
5.1
1 month 3.9
Extreme 3.9
5.23
Current year 2.56
Extreme 2.56
5.38
1 year 2.56
Extreme 2.56
12.72
3 years 2.56
Extreme 2.56
15.84
5 years 1.14
Extreme 1.14
15.84
10 years 0.42
Extreme 0.421
33.02
Manager TitleAgeSince
Chief Executive Officer 39 01/08/2025
Director of Finance/CFO 57 16/03/2026
Chief Tech/Sci/R&D Officer - 01/06/2026
Director TitleAgeSince
Chairman 65 -
Director/Board Member 75 04/09/2014
Chairman 43 11/06/2019
Date Insider Type Main position Quantity % Market Cap.
11/05Free

Chief Financial Officer

337,500 0.7035%
30/03Free

Responsable ventes & marketing

200,000 0.4155%
09/12Sell

Executive/Senior Manager

15,000 0.0312%
Change 5-day change 1-year change 3-year change Capi.($)
+7.27%+17.92%-61.04%+1.67% 236M
+4.62%+12.48%-32.20%-1.88% 31.31B
+1.81%+11.00%-31.80%+218.57% 15.19B
+0.48%+8.04%-15.44%+69.22% 5.91B
-8.94%-21.56% - - 2.41B
+5.52%+5.71% - - 2.23B
+2.62%+7.23%+44.20%-41.02% 1.96B
-8.30%-6.27%-29.07% - 1.14B
-0.34%+10.77%-33.12%+258.64% 826M
-5.71%+3.77%+560.00%+1,037.93% 756M
Average -0.10%+6.00%+50.19%+220.45% 6.2B
Weighted average by Cap. +2.56%+14.39%-20.02%+81.68%

Financials

2026 *2027 *
Net sales 222M 194M 178M 166M 315M 21.14B 320M 2.14B 833M 10.39B 833M 816M 35.81B 261M 228M 210M 195M 371M 24.84B 376M 2.52B 978M 12.21B 979M 958M 42.08B
Net income -13.11M -11.46M -10.54M -9.82M -18.63M -1.25B -18.91M -126M -49.17M -614M -49.23M -48.17M -2.12B 3.57M 3.12M 2.87M 2.68M 5.08M 340M 5.15M 34.47M 13.4M 167M 13.42M 13.13M 576M
Net Debt - -
Logo LifeMD, Inc.
LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.
Employees
350
Date Price Change Volume
02/07/26 USD 4.870 +7.27% 1,656,741
01/07/26 USD 4.540 +9.93% 1,903,807
30/06/26 USD 4.130 -1.67% 1,403,112
29/06/26 USD 4.200 +1.69% 1,412,801
26/06/26 USD 4.130 -1.67% 1,560,447
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
4.870USD
Average target price
9.875USD
Spread / Average Target
+102.77%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LFMD Stock